AI Science Tracker

University of Pennsylvania (de la Fuente lab)

1 discovery from 2025

Discoveries

Archaeasins: deep learning finds antibiotic candidates in the archaeal proteome

The APEX 1.1 deep learning platform scanned 233 archaeal proteomes and flagged 12,623 candidate antimicrobial molecules. Of 80 synthesized candidates, 93% showed in vitro activity against key pathogens, and three selected compounds reduced a drug-resistant bacterium in animal models after a single dose. Candidate and synthesis counts differ between press coverage and secondary reports, and the mouse details come from press coverage rather than the full text, so the paper's own figures should be checked.

Technology: APEX 1.1 deep learning antimicrobial peptide predictor

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: 80 top-ranked APEX-predicted peptides were synthesized and tested by broth microdilution MIC assays, then in mouse skin-abscess and thigh-infection models (six mice per group).
  • Still unknown: Authors state the model is sequence-based without structural information, pseudo-MIC labels may add noise, screening used only reviewed UniProt sequences, the thigh model did not prevent infection, efficacy declined between days 2 and 4 in the skin model, and only female mice were used.
  • AI role: APEX 1.1, a bacterial-strain-specific antimicrobial activity predictor, scored 193,331,608 peptides from the archaeome and selected candidates for synthesis.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12408343/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 87 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.